To determine the effect of CASC2 on the proliferation of bladder cancer cell in vitro, MTS assays showed that the overexpression of CASC2 apparently abrogated the proliferation rate of T24 and 5637 cells (P<0.05; Figure 2B and 2C). Here, CASC2 is linked to urinary bladder cancer.